J. B. Chemicals & Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 5/6
J. B. Chemicals & Pharmaceuticals has a total shareholder equity of ₹29.2B and total debt of ₹3.6B, which brings its debt-to-equity ratio to 12.2%. Its total assets and total liabilities are ₹39.9B and ₹10.7B respectively. J. B. Chemicals & Pharmaceuticals's EBIT is ₹8.0B making its interest coverage ratio 18. It has cash and short-term investments of ₹4.6B.
Key information
12.2%
Debt to equity ratio
₹3.57b
Debt
| Interest coverage ratio | 18x |
| Cash | ₹4.60b |
| Equity | ₹29.23b |
| Total liabilities | ₹10.71b |
| Total assets | ₹39.94b |
Recent financial health updates
We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt
Nov 29
Is J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Using Too Much Debt?
Dec 03J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Seems To Use Debt Quite Sensibly
Aug 03Does J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Have A Healthy Balance Sheet?
Mar 29J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Could Easily Take On More Debt
Nov 30Recent updates
J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar
Apr 19J. B. Chemicals & Pharmaceuticals Limited Just Missed Earnings - But Analysts Have Updated Their Models
Feb 09J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar
Dec 22We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt
Nov 29J. B. Chemicals & Pharmaceuticals' (NSE:JBCHEPHARM) Dividend Will Be Increased To ₹9.25
Aug 03J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Due To Pay A Dividend Of ₹8.50
Feb 11Is J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Using Too Much Debt?
Dec 03A Look At The Intrinsic Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)
Sep 21J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Seems To Use Debt Quite Sensibly
Aug 03Estimating The Fair Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)
Jun 15Does J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Have A Healthy Balance Sheet?
Mar 29J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Has Re-Affirmed Its Dividend Of ₹8.50
Feb 16With EPS Growth And More, J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Interesting
Jan 27J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Could Easily Take On More Debt
Nov 30Here's Why I Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Might Deserve Your Attention Today
Sep 24Are J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Investors Paying Above The Intrinsic Value?
Aug 03Do J. B. Chemicals & Pharmaceuticals's (NSE:JBCHEPHARM) Earnings Warrant Your Attention?
Jun 14How Does J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Fare As A Dividend Stock?
May 04Do J. B. Chemicals & Pharmaceuticals's (NSE:JBCHEPHARM) Earnings Warrant Your Attention?
Mar 13Financial Position Analysis
Short Term Liabilities: JBCHEPHARM's short term assets (₹18.5B) exceed its short term liabilities (₹8.7B).
Long Term Liabilities: JBCHEPHARM's short term assets (₹18.5B) exceed its long term liabilities (₹2.0B).
Debt to Equity History and Analysis
Debt Level: JBCHEPHARM has more cash than its total debt.
Reducing Debt: JBCHEPHARM's debt to equity ratio has increased from 1.7% to 12.2% over the past 5 years.
Debt Coverage: JBCHEPHARM's debt is well covered by operating cash flow (224.2%).
Interest Coverage: JBCHEPHARM's interest payments on its debt are well covered by EBIT (18x coverage).